Robert Clarke
Direttore/Membro del Consiglio presso SPEXIS AG
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Teofilo Raad | M | 54 | 7 anni | |
| Jeffrey Wager | M | 62 |
EnBiotix, Inc.
 EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | 3 anni |
| Kuno Sommer | M | 68 | 12 anni | |
| Robert Brooks | M | - |
Alphageneron Pharmaceuticals, Inc.
 Alphageneron Pharmaceuticals, Inc. BiotechnologyHealth Technology Alphageneron Pharmaceuticals, Inc. is a biotechnology company that specializes in developing antibody drug conjugates and natural killer. The company is based in Cambridge, MA. The company was founded by Robert K. Brooks and he has been the CEO since incorporation. | - |
| Michael Higgins | M | 61 | 9 anni | |
| Martin Jakobovic | M | - | - | |
| Paula Boggs | F | 64 |
The Johns Hopkins University
| - |
| Roger Heerman | M | - |
Kinaset Therapeutics, Inc.
 Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | - |
| Bernard Bollag | M | 63 | 11 anni | |
| Stephan Wehselau | M | 55 |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | 3 anni |
| Dennis Ausiello | M | 78 |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | 3 anni |
| Paul J. Mitchell | M | 71 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | 21 anni |
| Frazer Morgan | M | - |
Kinaset Therapeutics, Inc.
Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | - |
| David Hodgson | M | 67 |
The Johns Hopkins University
| - |
| Dan Hartman | M | 62 |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | 12 anni |
| Juergen Froehlich | M | 68 |
EnBiotix, Inc.
EnBiotix, Inc. Medical/Nursing ServicesHealth Services EnBiotix, Inc. operates as a late clinical-stage respiratory therapeutics company, which engages in deploying novel systems and synthetic biology technologies. It offers anti-persisters, engineered bacteriophage, tunable target degradation, and systems biology platform. Its pipeline includes ColiFin, EBX-001, EBX-002, and Linear Peptide Antibiotics. The company was founded by James J. Collins in 2012 and is headquartered in Boston, MA. | 3 anni |
| Beth Marek | F | - |
The Johns Hopkins University
| - |
| Edward G. Amoroso | M | - |
The Johns Hopkins University
| 8 anni |
| Andrew Eneim | M | - |
The Johns Hopkins University
| - |
| Lynn Johnson Langer | M | - |
The Johns Hopkins University
| - |
| Sean P. Keller | M | - |
The Johns Hopkins University
| - |
| Kay Kapoor | F | 61 |
The Johns Hopkins University
| - |
| Anne Scheurer | F | - |
The Johns Hopkins University
| - |
| Ciro de Quadros | M | - |
The Johns Hopkins University
| - |
| Chris Gibbons | M | - |
The Johns Hopkins University
| - |
| Mark Lowenthal | M | - |
The Johns Hopkins University
| - |
| David Hilden | M | - |
The Johns Hopkins University
| - |
| Michele Moore | F | - |
The Johns Hopkins University
| - |
| Kenneth J. Pienta | M | 64 |
The Johns Hopkins University
| 30 anni |
| Michael P. Boyle | M | - |
The Johns Hopkins University
| - |
| Walter Pinkard | M | - |
The Johns Hopkins University
| - |
| Myeong-Geun Lee | M | 66 |
The Johns Hopkins University
| - |
| Faisal Abualhassan | M | - |
The Johns Hopkins University
| - |
| Susan Daimler | F | 46 |
The Johns Hopkins University
| - |
| Ming Zhao Xing | M | 62 |
The Johns Hopkins University
| 13 anni |
| Susan Wismar | F | - |
The Johns Hopkins University
| - |
| Kevin Schollenberger | M | - |
The Johns Hopkins University
| - |
| Ann Koch | F | - |
The Johns Hopkins University
| - |
| Yaacov Rubin | M | - |
The Johns Hopkins University
| - |
| Charles Lowenstein | M | - |
The Johns Hopkins University
| - |
| Susan deMuth | F | - |
The Johns Hopkins University
| - |
| Paul Gasior | M | - |
The Johns Hopkins University
| - |
| Meghan Stark | F | - |
The Johns Hopkins University
| - |
| Adam Kaplin | M | 57 |
The Johns Hopkins University
| 22 anni |
| Matthias Stuber | M | - |
The Johns Hopkins University
| 22 anni |
| Rachel Pluviose | F | - |
The Johns Hopkins University
| - |
| Melissa Arnie | F | - |
The Johns Hopkins University
| - |
| Natalie Lorenz-Anderson | F | 61 |
The Johns Hopkins University
| - |
| Chirag Parikh | M | 51 |
The Johns Hopkins University
| 6 anni |
| Tony Ho | M | 58 |
The Johns Hopkins University
| - |
| Joseph T. Chadwick | M | - |
The Johns Hopkins University
| - |
| John Ruffle | M | 87 |
The Johns Hopkins University
| 34 anni |
| Samuel R. Denmeade | M | - |
The Johns Hopkins University
| - |
| Charles Homcy | M | 75 |
The Johns Hopkins University
| - |
| Roger Conant Faxon | M | 75 |
The Johns Hopkins University
| - |
| David Rubenstein | M | 74 |
The Johns Hopkins University
| - |
| Andrea Cox | M | - |
The Johns Hopkins University
| - |
| Joseph M. Davie | M | 84 |
The Johns Hopkins University
| - |
| Otis Brawley | M | 64 |
The Johns Hopkins University
| 5 anni |
| Steve C. Eastham | M | - |
The Johns Hopkins University
| - |
| Ronald M. Nordmann | M | 82 |
The Johns Hopkins University
| - |
| Frank Savage | M | 85 |
The Johns Hopkins University
| - |
| Mike Gutch | M | 58 |
The Johns Hopkins University
| - |
| Lenox D. Baker | M | 82 |
The Johns Hopkins University
| - |
| William C. Richardson | M | 82 |
The Johns Hopkins University
| 34 anni |
| Eric A. Amster | M | - |
The Johns Hopkins University
| - |
| Norm Augustine | M | 88 |
The Johns Hopkins University
| - |
| Timothy E. Sawyer | M | - |
The Johns Hopkins University
| - |
| David Sidransky | M | 64 |
The Johns Hopkins University
| 26 anni |
| Ronald Daniels | M | 64 |
The Johns Hopkins University
| 15 anni |
| Mayo Shattuck | M | 69 |
The Johns Hopkins University
| - |
| Daniel Francis Hanley | M | 72 |
The Johns Hopkins University
| 28 anni |
| Ernest Bates | M | - |
The Johns Hopkins University
| - |
| John W. Ellis | M | - |
The Johns Hopkins University
| - |
| Barbara White | M | 73 |
The Johns Hopkins University
| - |
| Shahin Samadi | M | - |
The Johns Hopkins University
| - |
| Marion W. Pines | F | - |
The Johns Hopkins University
| - |
| Antonia Hernández | F | 75 |
The Johns Hopkins University
| - |
| David R. Audley | M | - |
The Johns Hopkins University
| - |
| Lie Ping Chen | M | - |
The Johns Hopkins University
| - |
| Raj Ananthanpillai | M | - |
The Johns Hopkins University
| - |
| Drew Pardoll | M | - |
The Johns Hopkins University
| - |
| James N. Campbell | M | 76 |
The Johns Hopkins University
| - |
| Heather Murren | F | 57 |
The Johns Hopkins University
| - |
| Michael J. Breslow | M | - |
The Johns Hopkins University
| - |
| Levi Watkins | M | - |
The Johns Hopkins University
| - |
| Donald L. Price | M | - |
The Johns Hopkins University
| - |
| George Bayless | M | - |
The Johns Hopkins University
| - |
| Omar M. Knio | M | - |
The Johns Hopkins University
| - |
| Reginald Bartholomew | M | 88 |
The Johns Hopkins University
| - |
| Laurence M. Merlis | M | - |
The Johns Hopkins University
| - |
| Joseph E. Foss | M | - |
The Johns Hopkins University
| - |
| William L. Gertz | M | 73 |
The Johns Hopkins University
| - |
| Michael I. Miller | M | - |
The Johns Hopkins University
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michelle Siegert | F | 63 | - | |
| Kathryn L. Biberstein | F | 65 |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | - |
| William Duke | M | 51 | 4 anni | |
| Rebecca J. Peterson | F | 47 |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | 15 anni |
| Mark Iwicki | M | 57 | 6 anni | |
| Gökhan Batur | M | 42 | 3 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 96 | 96.00% |
| Svizzera | 9 | 9.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Robert Clarke
- Contatti personali
